HCA Healthcare (NYSE:HCA – Get Rating) had its price objective dropped by equities researchers at SVB Leerink from $304.00 to $273.00 in a note issued to investors on Monday, Benzinga reports. The brokerage presently has an “outperform” rating on the stock. SVB Leerink’s target price would indicate a potential upside of 29.61% from the stock’s […]